lifestyle.briefmobile.com

Author: NICOX SA

Nicox Provides Full Year 2025 Financial Results and Corporate Update

May 8, 2026
Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026

May 7, 2026
Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting

April 29, 2026
Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470

April 28, 2026
Nicox to Present Data from NCX 470 Phase 3 Studies at American Glaucoma Society (AGS) Annual Meeting 2026

March 9, 2026
Nicox annonce sa participation à des congrès au premier semestre 2026 et la présentation prochaine de données scientifiques

January 20, 2026